Skip to main content

Serum 5-Nucleotidase in Progressive Muscular Dystrophy

  • Chapter
Purine Metabolism in Man-III

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 122A))

  • 96 Accesses

Abstract

The information from the literature and personal observations cited hitherto indicate that a connection between purine metabolism and progressive muscular dystrophies may possibly exist. This is particularly valid for the metabolid end-product of purine, uric acid, which is frequently found to be increased in the blood-serum in the form of a symptomatic hyperuricaemia. The breakdown of nucleic acids or polynucleotides begins with their depolymerization to mononucleotides, which are subsequently split up into their components. The resulting purine bases, adenine and xanthine, are oxidized via the oxypurines hypoxanthine and xanthine to uric acid, and in this last stage the enzyme xanthine oxidase plays an important part. As the observations of CHALMERS et al. showed, the congenitab absence of xanthine oxidase may, after a long period, lead to a myopathy. Conversely, the inhibition of the enzyme with allopurinol in cases of muscular dystrophy with raised uric acid levels leads to a temporary and short-lived subjective improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BECKETT E.B. and BOURNE G.H.:5’Nucleotidase in normal and diseased human skeletal muscle Journal of Neuropathology and experimental Neurology 17: 199 (1958)

    Article  PubMed  CAS  Google Scholar 

  2. BOURNE G.H. and GOLARZ M.N. Human muscular dystrophy as an aberration of the connective tissue. Nature London. 183, 1741–1743 (1959)

    Article  PubMed  CAS  Google Scholar 

  3. CHALMERS R.A., JOHSON M., PALLIS C. and WATTS R.W.E.: Xanthinuria with Myopathy. Quart. J. Of Med., N.S. XXXVIII No. 152, 493–512 (1969)

    Google Scholar 

  4. CHOWDHURY S.R., PEARSON C.M. and FOWLER W.W.: Serum enzyme studies in muscular dystrophy III. Serum malic Dehydrogenase. 5!Nucleotidase and Adenosinetriphosphatase Proceedings of the Society for Experimental Biology and Medecine (New York) 109: 227 (1962)

    CAS  Google Scholar 

  5. LAHODA F.: Der erhöhte Harnsäurespiegel bei der Dystrophia musculorum progressiva ERB. Mediz. Monatsschrift 26, 12, 558–561 (1972)

    CAS  Google Scholar 

  6. PERSIJN J.P., VAN DER SLIK W.,TIMMER C.J. and REIJNTJES CM.:A new method for the Determination of Serum Nucleotidase, IV. Evaluation of the conditions for assays using adenosine deaminase. Zeitschrift für klinische Chemie und klinische Biochemie, 8. Jg.: 398–402 (1970)

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Plenum Press, New York

About this chapter

Cite this chapter

Làhoda, F., Baier, K. (1980). Serum 5-Nucleotidase in Progressive Muscular Dystrophy. In: Rapado, A., Watts, R.W.E., De Bruyn, C.H.M.M. (eds) Purine Metabolism in Man-III. Advances in Experimental Medicine and Biology, vol 122A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9140-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9140-5_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9142-9

  • Online ISBN: 978-1-4615-9140-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics